Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
2010 · Clinical Pharmacology & Therapeutics · 792 citations
https://doi.org/10.1038/clpt.2010.12
M
Marjolijn N. Lub–de Hooge
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
233
Papers
7.4K
Citations
44
h-index
79
i10-index
Marjolijn N. Lub–de Hooge is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Radiopharmaceutical Chemistry and Applications & Monoclonal and Polyclonal Antibodies Research & Medical Imaging Techniques and Applications. The author has an h-index of 44, co-authored 199 publications.
Papers by this author
worksIndium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
2006 · Journal of Clinical Oncology · 307 citations
https://doi.org/10.1200/jco.2005.03.8448
A review of bispecific antibodies and antibody constructs in oncology and clinical challenges
2019 · Pharmacology & Therapeutics · 288 citations
https://doi.org/10.1016/j.pharmthera.2019.04.006
89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
2018 · European Journal of Nuclear Medicine and Molecular Imaging · 134 citations
https://doi.org/10.1007/s00259-018-4099-8
89Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft
2009 · European Journal of Cancer · 98 citations
https://doi.org/10.1016/j.ejca.2009.12.009
Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review
2023 · Clinical Pharmacokinetics · 60 citations
https://doi.org/10.1007/s40262-023-01225-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat